lisocabtagene maraleucel
bms
['lymsm']
liso-cel elicits significant second-line activity in frail patients with relapsed/refractory lbcl #asco22 #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.